EP1992628A1 — Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
Assigned to Glaxo Group Ltd · Expires 2008-11-19 · 17y expired
What this patent protects
This invention provides a compound of formula (I) or a pharmaceutically acceptable salt, solvate or N-oxide thereof: The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (…
USPTO Abstract
This invention provides a compound of formula (I) or a pharmaceutically acceptable salt, solvate or N-oxide thereof: The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (I) and to the use of compounds of formula (I) in the manufacture of a medicament for use in the treatment of bacterial infections including tuberculosis in mammals.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.